NCT05320835Recruiting
A Setting Focus Overdose Prevention Intervention
A Geospatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs in Baltimore, Maryland
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 285 (estimated)
- First submitted
- 30 Mar 2022
- Start date
- 30 Apr 2022
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Diseases
- HIV
- NCT number
- NCT05320835
What you commit to
- Study type: Interventional
- Planned participants: 285
- From 30 Apr 2022 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any mental or physical health impairment that impedes ability to participate
Who the study is looking for
- Current drug user (opioid use in the prior two weeks)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lighthouse Studies at Peer Point Coordinator of this site? Confirm its status | Baltimore | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.